MS Speaks
Here for 17 years--for people with an interest in multiple sclerosis
Welcome,
Guest
. Please
login
or
register
.
1 Hour
1 Day
1 Week
1 Month
Forever
Login with username, password and session length
This topic
This board
Entire forum
Home
Search
Today's Posts
Contact
Login
Register
MS Speaks 5/06 to 11/13
MS Speaks
»
Forum
»
Multiple Sclerosis
»
MS - RESEARCH AND NEWS
»
Phase 2b trial for MIS416 for SPMS
»
Message #2178
« previous
next »
Print
Pages: [
1
]
Author
Topic: Phase 2b trial for MIS416 for SPMS (Read 225 times)
0 Members and 1 Guest are viewing this topic.
agate
Administrator
Posts: 9841
MS diagnosed 1980
Location: Pacific Northwest
MIS416 failed Phase II clinical trial
«
on:
August 09, 2018, 08:55:03 pm »
This is old news but may have some relevance to the US national news just now--from the National MS Society Website:
https://www.nationalmssociety.org/About-the-Society/News/Results-Announced-from-Phase-2-Trial-of-MIS416-in
From the Washington Post (August 8, 2016) there is the news that Representative Chris Collins (Rep., NY) is under indictment for insider training. It seems he was a stockholder in Innate Immunotherapeutics, which was developing a new drug for secondary progressive MS. He had knowledge about the failure of the clinical trial and passed that information along to relatives, advising them to dump their stock, before this was public knowledge. Although the drug hasn't been named, my guess is that it was MIS 416.
https://www.washingtonpost.com/business/2018/08/08/rep-christopher-collins-r-ny-charged-with-insider-trading-federal-prosecutors-announce/?utm_term=.ded4bf4c9ef1
Report to moderator
Logged
MS Speaks--online for 17 years
SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Print
Pages: [
1
]
« previous
next »
MS Speaks
»
Forum
»
Multiple Sclerosis
»
MS - RESEARCH AND NEWS
»
Phase 2b trial for MIS416 for SPMS
»
Message #2178